Research Topics
Genomes and GenesSpecies | Shaila MisriSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Paroxetine use in the treatment of premenstrual dysphoric disorderShaila Misri
University of British Columbia, 2329 West Mall, Vancouver, BC, B6T 1Z4, Canada
Womens Health (Lond Engl) 2:43-51. 2006..This article reviews the properties of this medication and its use in the treatment of premenstrual dysphoric disorder...- Treatment of perinatal mood and anxiety disorders: a reviewShaila Misri
University of British Columbia, Vancouver
Can J Psychiatry 52:489-98. 2007.... - Quetiapine augmentation in lactation: a series of case reportsShaila Misri
The University of British Columbia, Vancouver, BC, Canada
J Clin Psychopharmacol 26:508-11. 2006..These results should be interpreted with caution, and vigilance should be exercised when advising women on combinations of medications for severe mental illness who choose to nurse... - Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medicationsShaila Misri
Reproductive Mental Health Program, St Paul s Hospital, Rm 2B 185, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
Am J Psychiatry 163:1026-32. 2006..The authors had previously reported the effects of prenatal medication exposure in this same cohort when they were newborns and infants at 3 and 8 months of age... - The impact of treatment intervention on parenting stress in postpartum depressed mothers: a prospective studyShaila Misri
BC Women s Hospital, Reproductive Mental Health Program, Vancouver, BC, Canada
Am J Orthopsychiatry 76:115-9. 2006..In addition to monitoring of depressive symptoms, routine assessment of maternal parenting qualities is recommended to ensure healthy child outcomes... - Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentationShaila Misri
Department of Psychiatry, University of British Columbia, British Columbia, Canada
J Clin Psychopharmacol 24:624-7. 2004..The objective of this open-label study was to evaluate clinical response to quetiapine augmentation of SSRIs or SNRIs in treatment-resistant OCD in the postpartum... - The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trialShaila Misri
Department of, Faculty of Medicine, University of British Columbia and Reproductive Mental Health Programs, St Paul s Hospital, Vancouver, British Columbia, Canada
J Clin Psychiatry 65:1236-41. 2004.... 
Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposureTim F Oberlander
Department of Pediatrics, UBC, Vancouver, BC, Canada V6H 3V4
Early Hum Dev 84:689-97. 2008....- Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective studyShaila Misri
Department of Psychiatry and Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia
Can J Psychiatry 55:222-8. 2010..We studied the effect of antenatal depression and anxiety and treatment with selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors (antidepressants [ADs]) on postpartum parenting stress... - Relation between prenatal maternal mood and anxiety and neonatal healthShaila Misri
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 49:684-9. 2004..To examine the relation between the mood and anxiety of pregnant, psychiatrically treated women and neonatal health outcomes after birth... - Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based studyTim F Oberlander
Early Human Experience Unit, Centre for Community Child Health Research, Vancouver, BC, Canada
Br J Psychiatry 192:338-43. 2008..Late-gestational serotonin reuptake inhibitor (SRI) exposure has been linked to adverse neonatal outcomes; however, the impact of timing and duration of exposure is unknown... - Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of ageTim F Oberlander
Early Human Experience Unit, Developmental Neurosciences and Child Health, and Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada
Arch Pediatr Adolesc Med 164:444-51. 2010.... - Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposureTim F Oberlander
Department of Pediatrics, Centre for Community Child Health Research, University of British Columbia, L408 4480 Oak Street, Vancouver, BC, Canada V6H 3V4
J Clin Psychiatry 65:230-7. 2004..Also, this study explores relationships between neonatal outcomes and medication levels during pregnancy, at delivery, and in the newborn period... - Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health dataTim F Oberlander
Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Birth Defects Res B Dev Reprod Toxicol 83:68-76. 2008..To determine a population-based incidence of congenital anomalies following prenatal exposure to serotonin reuptake inhibitor (SRI) antidepressants used alone and in combination with a benzodiazepines (BZ)... 
Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feedingJohn Kim
Department of Psychiatry, University of British Columbia
Br J Clin Pharmacol 61:155-63. 2006..Increased exposure may also result from decreased metabolism of the drug in the foetus and neonate...- Biopsychosocial determinants of treatment outcome for mood and anxiety disorders up to 8 months postpartumShaila Misri
Reproductive Mental Health Program, St Paul s Hospital, Vancouver, BC, Canada
Arch Womens Ment Health 15:313-6. 2012..Biological and psychosocial variables predicted pharmacological treatment outcome in postpartum-depressed and anxious women... - Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancyTim F Oberlander
Department of Pediatrics, Human Early Experience Unit, Centre for Community Child Health Research, Research Institute for Children s and Women s Health, University of British Columbia, 4480 Oak Street, Vancouver, BC, Canada V6 3V4
Arch Pediatr Adolesc Med 161:22-9. 2007..To evaluate attentional and activity behaviors in 4-year-olds following prenatal selective serotonin reuptake inhibitor (SSRI) exposure... - Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responsesTim F Oberlander
Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada
Epigenetics 3:97-106. 2008.... - Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health dataTim F Oberlander
Department of Pediatrics, Human Early Learning Partnership, Faculty of Graduate Studies, University of British Columbia, Vancouver
Arch Gen Psychiatry 63:898-906. 2006..Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants and maternal depression both alter neonatal health, and distinguishing the effects of each influence remains challenging... - Managing unipolar depression in pregnancyJulia Raudzus
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Curr Opin Psychiatry 22:13-8. 2009.... - Benefits and risks to mother and infant of drug treatment for postnatal depressionShaila Misri
Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Drug Saf 25:903-11. 2002..It is critical that healthcare providers evaluate each mother-infant dyad on an individual basis when faced with the decision to prescribe antidepressant medications during the postnatal period... - Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the riskSheila W Patton
University of British Columbia, Vancouver, British Columbia
Can J Psychiatry 47:959-65. 2002.... - Psychologic aspects of early pregnancy lossDiana Carter
Departments of Psychiatry, Faculty of Medicine, University of British Columbia, Canada
Clin Obstet Gynecol 50:154-65. 2007..The course and impact of these disorders on a grieving mother and her partner are discussed and treatment recommendations are made. The psychologic effects of therapeutic abortion are also be briefly discussed... - Platelet serotonin levels support depression scores for women with postpartum depressionElisabeth Maurer-Spurej
Canadian Blood Services, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
J Psychiatry Neurosci 32:23-9. 2007..This study examined whether a new measurement for platelet serotonin could aid in the diagnosis of postpartum depression and support the results from questionnaires... - Prolonged prenatal psychotropic medication exposure alters neonatal acute pain responseTim F Oberlander
Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Pediatr Res 51:443-53. 2002..Possible 5HT-mediated pain inhibition, pharmacologic factors and the developmental course remain to be studied... - Suffering in silence: the burden of perinatal depressionShaila Misri
Can J Psychiatry 52:477-8. 2007